🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsCardiovascular OutcomesArterial stiffness reduction on GLP-1 — looking for input Page 4

Arterial stiffness reduction on GLP-1 — looking for input

RickReta_CO Thu, Feb 19, 2026 at 5:44 AM 21 replies 1,183 viewsPage 4 of 5
Dr.ReproEndo
Senior Member
1,890
8,901
Jan 2024
Scottsdale, AZ
Mar 6, 2026 at 6:59 AM#16
TrialTracker_MD said:
Positive "side effect" of cardiovascular risk: my blood pressure dropped so much that I'm now off losartan entirely!

This matches mine closely enough to be worth saying so out loud.

Last edited: Mar 6, 2026 at 7:59 AM
8 8mona_PHX, andrew_nyc, Dr.EndoEP and 5 others
Reply Quote Save Share Report
sarah.morrison
VIP Member
3,212
14,567
Jan 2024
California
Online
Mar 8, 2026 at 3:05 PM#17
lucas_SP_BR said:
I'm 55 years old and want to share my perspective on cardiovascular risk as an older member of this community.

Saving this. It is the first explanation that did not require me to already understand it. Taking it to my next appointment.

7 7roxy_nash, tony_orlando, Dr.NephBHM_UK and 4 others
Reply Quote Save Share Report
sophie_paris
Member
212
890
Nov 2024
Paris, FR
Mar 10, 2026 at 11:13 PM#18

From the other side of the consultation, briefly.

CRP reduction on cardiovascular risk — this is the lab result that excites me most:

Baseline hsCRP: 11.0 mg/L (high cardiovascular risk)
Month 6 hsCRP: 1.5 mg/L (moderate risk)
Month 12 hsCRP: 0.6 mg/L (low risk)

This level of inflammatory marker reduction is comparable to what you'd see with statin therapy. Combined with the weight loss, my 10-year ASCVD risk score dropped from 18% to 4%. My cardiologist is genuinely impressed.

6 6MariaRD, AussieAnna, BethLabQueen and 3 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
pam_stl
Member
267
1,123
Oct 2024
St. Louis, MO
Mar 13, 2026 at 7:22 AM#19
sophie_paris said:
CRP reduction on cardiovascular risk — this is the lab result that excites me most: Baseline hsCRP: 11.0 mg/L (high cardiovascular risk) Month 6…

Second this.

Last edited: Mar 13, 2026 at 12:22 PM
5 5SleepDoc_PDX, RegAffairsDC, BiostatsBrad and 2 others
Reply Quote Save Share Report
Admin
Administrator
2,456
9,812
Oct 2023
Online
Mar 15, 2026 at 3:32 PM#20

Moderator note: leaving this open. It is being argued well and the disagreement is the useful part.

Last edited: Mar 15, 2026 at 7:32 PM
33 8PeptideSynthNJ, Dr.KarenChen, Dr.NateNeph and 30 others
Reply Quote Save Share Report

Similar Threads

SELECT trial: 20% MACE reduction — mechanistic deep dive7 replies
Semaglutide cardiovascular benefit independent of weight loss11 replies
STEP-HFpEF: semaglutide in heart failure with preserved EF15 replies
GLP-1 and arterial inflammation — hsCRP and IL-6 reduction data18 replies
Lp(a) on GLP-1 agonists — any impact on this risk factor?8 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register